Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Starling Oncology Inc., 3 years.
Starling Oncology Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 27, 2026 | Starling Oncology Inc. | Grant or award | +33,133 | — | — |
| Apr 16, 2026 | Starling Oncology Inc. | Open-market sale | −38,433 | $3.50 | $134,516 |
| Apr 14, 2026 | Starling Oncology Inc. | Open-market sale | −57,286 | $3.50 | $200,501 |
| Nov 20, 2025 | Starling Oncology Inc. | Grant or award | +50,926 | — | — |
| Nov 20, 2025 | Starling Oncology Inc. | Grant or award | +40,123 | — | — |
| Nov 22, 2024 | Starling Oncology Inc. | Grant or award | +56,000 | — | — |
| Dec 26, 2023 | Starling Oncology Inc. | Grant or award | +53,326 | — | — |
| Mar 17, 2023 | Starling Oncology Inc. | Grant or award | +19,685 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.